Tevogen Bio Holdings, Inc. logo

Tevogen Bio Holdings, Inc.

TVGNNASDAQ

Tevogen Bio Holdings, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Ryan H. Saadi, with a market cap of $56.4M.

CEORyan H. Saadi
Market Cap$56.4M
Biotechnology
Healthcare
Employees17.0
Country
United States of America

Next Earnings

Upcoming earnings announcement for Tevogen Bio Holdings, Inc.

Date
Wednesday, April 1, 2026 (in 2 months)
Timing
Before Market Open (1:00 AM New York)
Fiscal Period
Q4 2025
EPS Estimate
-$0.03

Earnings History

Past 6 earnings reports for Tevogen Bio Holdings, Inc.

DatePeriodEPSEPS SurpriseRevenueRev. SurpriseFiling
Nov 14, 2025Q3 2025
-$0.03Est: -$0.06
+50.0%
-
SEC10-Q
Aug 14, 2025Q2 2025
-$0.03
-
SEC10-Q
Apr 2, 2025Q4 2024
-$0.06
-
SEC10-K
Nov 19, 2024Q3 2024
-$0.03
-
SEC10-Q
Aug 14, 2024Q2 2024
-$0.04
-
SEC10-Q
May 29, 2024Q1 2024
-$0.26
-
SEC10-Q

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.